ATF3 gene regulates cell form and migration potential of HT29 colon cancer cells

Oncology Research

Volumn 12, Issue 8, 2000, Pages 343-346

  Ishiguro, Tatsuaki ^a   Nagawa, Hirokazu ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

ATF3 gene; Cell form; Cell migration; HT29 colon cancer cells

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 3; ANTINEOPLASTIC AGENT; ANTISENSE OLIGONUCLEOTIDE; TRANSCRIPTION FACTOR;

ARTICLE; CELL MOTION; CELL SIZE; CELL STRAIN HT29; COLON TUMOR; DRUG EFFECT; FLOW CYTOMETRY; GENETICS; HUMAN; PATHOLOGY; PHYSIOLOGY;

ACTIVATING TRANSCRIPTION FACTOR 3; ANTINEOPLASTIC AGENTS; CELL MOVEMENT; CELL SIZE; COLONIC NEOPLASMS; FLOW CYTOMETRY; HT29 CELLS; HUMANS; OLIGONUCLEOTIDES, ANTISENSE; TRANSCRIPTION FACTORS;

EID: 0034575397     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: 10.3727/096504001108747792     Document Type: Article

References (15)

1. Fidler, I. J. Critical factors in the biology of human cancer metastasis: 28th G.H.A. Clowes Memorial Awards Lecture. Cancer Res. 50:6130-6138; 1990.
2. Poste, G.; Doll, J.; Hart, I. R.; Fidler, I. J. In vitro selection of murine B16 melanoma variants with enhanced tissue-invasive properties. Cancer Res. 40:1636-1644; 1988.
3. Ishiguro, T.; Nakajima, M.; Naito, M.; Muto, T.; Tsuruo, T. Identification of genes differentially expressed in B16 murine melanoma sublines with different metastatic potentials. Cancer Res. 56(4):875-879; 1996.
4. Hsu, J. C.; Bravo, R.; Taub, R. Interactions among LRF-1, Jun B, c-Jun, and c-Fos define a regulatory program in the G1 phase of liver regeneration. Mol. Cell. Biol. 12:4654-4665; 1992.
5. Ishiguro, T.; Nagawa, H.; Naito, M.; Tsuruo, T. Inhibitory effect of ATF3 antisense oligonucleotides on ectopic growth of HT29 human colon cancer cells. Jpn. J. Cancer Res. 91(8):833-836; 2000.
6. Chung, C. Y.; Pallero, M. A.; Murphy-Ullrich, J. E.; Erickson, H. P. Mitogenesis, cell migration, and loss of focal adhesions induced by tenascin-C interacting with its cell surface receptor, annexin II. Mol. Biol. Cell 7:883-892; 1996.
7. Hsu, J. C.; Cressman, D. E.; Taub, R. Promoter-specific transactivation and inhibition mediated by Jun B. Cancer Res. 53: 3789-3794; 1993.
8. Wolfgang, C. D.; Chen, B. P.; Martindale, J. L.; Holbrook, N. J.; Hai, T. Gadd153/Chop10, a potential target of the transcriptional repressor ATF3. Mol. Cell. Biol. 17:6700-6707; 1997.
9. Kaszubska, W.; Hooft, H. R.; Ghersa, P.; DeRaemy-Schenk, A. M.; Chen, B. P.; Hai, T.; Delamarter, J. F.; Whelan, J. Cyclic AMP-independent ATF family members interact with NF-kappa B and function in the activation of the E-selectin promoter in response to cytokines. Mol. Cell. Biol. 13:7180-7190; 1993.
10. Taniguchi, S.; Tatsuka, M.; Nakamatsu, K.; Inoue, M.; Sadano, H.; Okazaki, H.; Iwamoto, H.; Baba, T. High invasiveness associated with augmentation of motility in a fos-transferred highly metastatic rat 3Y1 cell line. Cancer Res. 49(23):6738-6744; 1989.
11. Smith, L. M.; Wise, S. C.; Hendricks, D. T.; Sabichi, A. L.; Bos, T.; Reddy, P.; Brown, P. H.; Birrer, M. J. cJun overexpression in MCF-7 breast cancer cells produces a tumorigenic, invasive and hormone resistant phenotype. Oncogene 18(44):6063-6070; 1999.
12. Tran, P. O.; Hinman, L. E.; Unger, G. M.; Sammak, P. J. A wound-increased [Ca2+]i increase and its transcriptional activation of immediate early genes is important in the regulation of motility. Exp. Cell. Res. 246(2):319-326; 1999.
13. Shestakova, E. A.; Wyckoff, J.; Jones, J.; Singer, R. H.; Condeelis, J. Correlation of beta-actin messenger RNA localization with metastatic potential in rat adenocarcinoma cell lines. Cancer Res. 59(6):1202-1205; 1999.
14. Yoshida, K.; Nakamori, S.; Itoh, K. Overexpression of small GTP-binding protein Rho A promotes invasion of tumor cells. Cancer Res. 59(8):2004-2010; 1999.
15. Cooper, C. R.; Donald, C.; Emmnett, N.; Harris-Hooker, S.; Cooke, D. B., 3rd. Adhesion and invasion potential of rat prostatic cancer cells: Correlation with metastatic potential. Invasion Metastasis 13(4):178-184; 1993.